Quarterly report · Q2
5199.TEDINET S100PKP3
Period2022-04-01 → 2022-09-30
Filed2022-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥8.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥4.1bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥373m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥425m | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥370m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥486m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥409m | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥362m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥341m | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥258m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥143m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥214m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥258m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥214m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥11.5bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥11.8bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥12.4bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥8.2bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥8.7bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥3.3bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥3.1bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.5bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.8bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.9bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.5bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.6bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.3bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥406m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.2bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥778m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥24m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥152m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥35m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥516m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥803m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥599m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥203.31 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥100.5 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-112.56 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥168.33 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥47.15 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 28.8% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.2% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.0% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 26
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥230m |
| jpcrp040300-q2r_E01109-000Medical Equipmentreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E01109-000Medical Equipmentreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E01109-000Medical Equipmentreportable segment | segment profit | 2022-04-01 → 2022-09-30 | −¥55m |
| jpcrp040300-q2r_E01109-000Precision Equipmentreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥2.6bn |
| jpcrp040300-q2r_E01109-000Precision Equipmentreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥2.6bn |
| jpcrp040300-q2r_E01109-000Precision Equipmentreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥601m |
| jpcrp040300-q2r_E01109-000SPreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥194m |
| jpcrp040300-q2r_E01109-000SPreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥194m |
| jpcrp040300-q2r_E01109-000SPreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥11m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥4.2bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥4.2bn |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥603m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-09-30 | −¥232m |
| jpcrp040300-q2r_E01109-000Medical Equipmentreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥1.1bn |
| jpcrp040300-q2r_E01109-000Medical Equipmentreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥1.1bn |
| jpcrp040300-q2r_E01109-000Medical Equipmentreportable segment | segment profit | 2021-04-01 → 2021-09-30 | −¥24m |
| jpcrp040300-q2r_E01109-000Precision Equipmentreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥2.7bn |
| jpcrp040300-q2r_E01109-000Precision Equipmentreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥2.7bn |
| jpcrp040300-q2r_E01109-000Precision Equipmentreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥671m |
| jpcrp040300-q2r_E01109-000SPreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥168m |
| jpcrp040300-q2r_E01109-000SPreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥168m |
| jpcrp040300-q2r_E01109-000SPreportable segment | segment profit | 2021-04-01 → 2021-09-30 | −¥5m |
| —segment total | revenue | 2021-04-01 → 2021-09-30 | ¥4.1bn |
| —segment total | revenue external | 2021-04-01 → 2021-09-30 | ¥4.1bn |
| —segment total | segment profit | 2021-04-01 → 2021-09-30 | ¥657m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 499
| Item | Context | Value | Unit |
|---|---|---|---|
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | － | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | － | JPY |
| Income before income taxes | Prior1YTDDuration | 341072000 | JPY |
| Income before income taxes | CurrentYTDDuration | 362438000 | JPY |
| Depreciation and amortization ope cf | Prior1YTDDuration | 231361000 | JPY |
| Depreciation and amortization ope cf | CurrentYTDDuration | 177742000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | Prior1YTDDuration | -28000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | CurrentYTDDuration | 27000 | JPY |
| Impairment loss ope cf | Prior1YTDDuration | 67493000 | JPY |
| Impairment loss ope cf | CurrentYTDDuration | 7523000 | JPY |
| Interest and dividends income ope cf | Prior1YTDDuration | -4317000 | JPY |
| Interest and dividends income ope cf | CurrentYTDDuration | -4974000 | JPY |
| Insurance income ope cf | Prior1YTDDuration | -25000 | JPY |
| Insurance income ope cf | CurrentYTDDuration | -1000000 | JPY |
| Interest expenses ope cf | Prior1YTDDuration | 34868000 | JPY |
| Interest expenses ope cf | CurrentYTDDuration | 30093000 | JPY |
| Commission for syndicate loan ope cf | Prior1YTDDuration | 4156000 | JPY |
| Commission for syndicate loan ope cf | CurrentYTDDuration | 4474000 | JPY |
| Amortization of bond issuance cost ope cf | Prior1YTDDuration | 1033000 | JPY |
| Amortization of bond issuance cost ope cf | CurrentYTDDuration | 1685000 | JPY |
| Loss on retirement of property plant and equipment ope cf | Prior1YTDDuration | 0 | JPY |
| Loss on retirement of property plant and equipment ope cf | CurrentYTDDuration | 10000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YTDDuration | -121405000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYTDDuration | 54626000 | JPY |
| Decrease increase in inventories ope cf | Prior1YTDDuration | -18297000 | JPY |
| Decrease increase in inventories ope cf | CurrentYTDDuration | -24010000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YTDDuration | 255457000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYTDDuration | 132778000 | JPY |
| Increase decrease in provision for bonuses ope cf | Prior1YTDDuration | 25653000 | JPY |
| Increase decrease in provision for bonuses ope cf | CurrentYTDDuration | -32664000 | JPY |
| Increase decrease in net defined benefit liability ope cf | Prior1YTDDuration | -11605000 | JPY |
| Increase decrease in net defined benefit liability ope cf | CurrentYTDDuration | -37268000 | JPY |
| Other net ope cf | Prior1YTDDuration | 24492000 | JPY |
| Other net ope cf | CurrentYTDDuration | -94062000 | JPY |
| Subtotal ope cf | Prior1YTDDuration | 829907000 | JPY |
| Subtotal ope cf | CurrentYTDDuration | 577421000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YTDDuration | 4317000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYTDDuration | 4974000 | JPY |
| Proceeds from insurance income ope cf | Prior1YTDDuration | 25000 | JPY |
| Proceeds from insurance income ope cf | CurrentYTDDuration | 1000000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YTDDuration | -34634000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYTDDuration | -29992000 | JPY |
| Income taxes paid refund ope cf | Prior1YTDDuration | -21702000 | JPY |
| Income taxes paid refund ope cf | CurrentYTDDuration | -147623000 | JPY |
| Net cash provided by used in operating activities | Prior1YTDDuration | 777914000 | JPY |
| Net cash provided by used in operating activities | CurrentYTDDuration | 405779000 | JPY |
| Purchase of property plant and equipment inv cf | Prior1YTDDuration | -32003000 | JPY |
| Purchase of property plant and equipment inv cf | CurrentYTDDuration | -16561000 | JPY |
| Purchase of intangible assets inv cf | Prior1YTDDuration | -2779000 | JPY |
| Purchase of intangible assets inv cf | CurrentYTDDuration | -3784000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |